The clinical value of therapeutic plasma exchange in multifocal motor neuropathy

Journal of the Neurological Sciences

Volumn 271, Issue 1-2, 2008, Pages 34-39

  Lehmann, Helmar C ^a   Hoffmann, Felix R ^a   Fusshoeller, Andreas ^a   zu Hörste, Gerd Meyer ^a   Hetzel, Rüdiger ^a   Hartung, Hans Peter ^a   Schroeter, Michael ^a,b   Kieseier, Bernd C ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Axonal degeneration; Ganglioside; Plasma exchange; Polyneuropathy

Indexed keywords

GANGLIOSIDE ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; ELECTROPHYSIOLOGY; FEMALE; HUMAN; IMMUNOASSAY; MALE; MOTOR NEUROPATHY; MULTIFOCAL MOTOR NEUROPATHY; NERVE CONDUCTION; NERVE FIBER DEGENERATION; PLASMAPHERESIS; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; AGED; ANTIBODIES; FEMALE; FOLLOW-UP STUDIES; GANGLIOSIDES; HUMANS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; NEURAL CONDUCTION; PLASMA EXCHANGE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 44449155374     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.02.022     Document Type: Article

References (21)

1. Van Asseldonk J.T., Franssen H., Van den Berg-Vos R.M., Wokke J.H., and Van den Berg L.H. Multifocal motor neuropathy. Lancet Neurol 4 (2005) 309-319
2. European Federation of Neurological Societies. Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 11 (2006) 1-8
3. Taylor B.V., Dyck P.J., Engelstad J., Gruener G., Grant I., and Dyck P.J. Multifocal motor neuropathy: pathologic alterations at the site of conduction block. J Neuropathol Exp Neurol 63 (2004) 129-137
4. Nobile-Orazio E. Multifocal motor neuropathy. J Neuroimmunol 115 (2001) 4-18
5. van Asseldonk J.T.H., Van den Berg L.H., Kalmijn S., Van den Berg-Vos R.M., Polman C.H., Wokke J.H.J., and Franssen H. Axon loss is an important determinant of weakness in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 77 (2006) 743-747
6. Léger J.M., Chassandre B., Musset L., Meininger V., Bouche P., and Baumann N. Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study. Brain 124 (2001) 145-153
7. Willison H.J., and Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 125 (2002) 2591-2625
8. Dyck P.J., Daube J., O'Brien P., Pineda A., Low P.A., Windebank A.J., and Swanson C. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 314 (1986) 461-465
9. Dyck P.J., Low P.A., Windebank A.J., Jaradeh S.S., Gosselin S., Bourque P., Smith B.E., Kratz K.M., Karnes J.L., Evans B.A., et al. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med 325 (1991) 1482-1486
10. Feldman E.L., Bromberg M.B., Albers J.W., and Pestronk A. Immunosuppressive treatment in multifocal motor neuropathy. Ann Neurol 30 (1991) 397-401
11. Specht S., Claus D., and Zieschang M. Plasmapheresis in multifocal motor neuropathy: a case report. J Neurol Neurosurg Psychiatry 68 (2000) 533-535
12. Carpo M., Cappellari A., Mora G., Pedotti R., Barbieri S., Scarlato G., and Nobile-Orazio E. Deterioration of multifocal motor neuropathy after plasma exchange. Neurology 50 (1998) 1480-1482
13. Nobile-Orazio E., Cappellari A., Meucci G., Carpo M., Terenghi F., Bersano A., Priori A., Berbieri S., and Scarlato G. Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of conduction block. J Neurol Neurosurg Psychiatry 72 (2002) 761-766
14. Willison H.J., Veitch J., Swan A.V., Baumann N., Comi G., Gregson N.A., Illa I., Jacobs B.C., Zielasek J., and Hughes R.A. Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies. Eur J Neurol 6 (1999) 71-77
15. Lehmann H.C., Hartung H.P., Hetzel G.R., Stüve O., and Kieseier B.C. Plasma exchange in neuroimmunological disorders. Part 2 Treatment of neuromuscular disorders. Arch Neurol 63 (2006) 1066-1071
16. Carpo M., Cappellari A., Mora G., Pedotti R., Barbieri S., Scarlato G., and Nobile-Orazio E. Deterioration of multifocal neuropathy after plasma exchange. Neurology 50 (1998) 1480-1482
17. Pestronk A., Cornblath D.R., Ilyas A., Baba H., Quarles R.H., Griffin J.W., Alderson K., and Adams R.N. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 24 (1988) 73-78
18. Ruegg S.J., Fuhr P., and Steck A. Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIg. Neurology 63 (2004) 2178-2179
19. Press R., Mata S., Lolli F., Zhu J., Andersson T., and Link H. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barre syndrome. J Neurol Sci 190 (2001) 41-47
20. Yuki N., Sato S., Inuzuka T., Miyatake T., and Yoshino H. Axonal degeneration in the Guillain-Barre syndrome and anti-GM1 ganglioside antibodies. Muscle Nerve 15 (1992) 116
21. Yuki N., Yamada M., Koga M., Odaka M., Susuki K., Tagawa Y., Ueda S., Kasama T., Ohnishi A., Hayashi S., Takahashi H., Kamijo M., and Hirata K. Animal model of axonal Guillain-Barre syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 49 (2001) 712-720